Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Vasileios, Kourafalos"'
Autor:
Evelien Moorkens, Brian Godman, Isabelle Huys, Iris Hoxha, Admir Malaj, Simon Keuerleber, Silvia Stockinger, Sarah Mörtenhuber, Maria Dimitrova, Konstantin Tachkov, Luka Vončina, Vera Vlahović Palčevski, Gnosia Achniotou, Juraj Slabý, Leona Popelková, Kateřina Kohoutová, Dorthe Bartels, Ott Laius, Jaana E. Martikainen, Gisbert W. Selke, Vasileios Kourafalos, Einar Magnússon, Rannveig Einarsdóttir, Roisín Adams, Roberta Joppi, Eleonora Allocati, Arianit Jakupi, Anita Viksna, Ieva Greičiūtė-Kuprijanov, Patricia Vella Bonanno, Vincent Suttorp, Øyvind Melien, Robert Plisko, Ileana Mardare, Dmitry Meshkov, Tanja Novakovic, Jurij Fürst, Corinne Zara, Vanda Marković-Peković, Nataša Grubiša, Gustaf Befrits, Robert Puckett, Arnold G. Vulto
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
Background: From October 2018, adalimumab biosimilars could enter the European market. However, in some countries, such as Netherlands, high discounts reported for the originator product may have influenced biosimilar entry.Objectives: The aim of thi
Externí odkaz:
https://doaj.org/article/91efa0738a404ac58954a5cf23bc3c10
Autor:
Brian Godman, Magdalene Wladysiuk, Stuart McTaggart, Amanj Kurdi, Eleonora Allocati, Mihajlo Jakovljevic, Francis Kalemeera, Iris Hoxha, Anna Nachtnebel, Robert Sauermann, Manfred Hinteregger, Vanda Marković-Peković, Biljana Tubic, Guenka Petrova, Konstantin Tachkov, Juraj Slabý, Radka Nejezchlebova, Iva Selke Krulichová, Ott Laius, Gisbert Selke, Irene Langner, András Harsanyi, András Inotai, Arianit Jakupi, Svens Henkuzens, Kristina Garuolienė, Jolanta Gulbinovič, Patricia Vella Bonanno, Jakub Rutkowski, Skule Ingeberg, Øyvind Melien, Ileana Mardare, Jurij Fürst, Sean MacBride-Stewart, Carol Holmes, Caridad Pontes, Corinne Zara, Marta Turu Pedrola, Mikael Hoffmann, Vasileios Kourafalos, Alice Pisana, Rita Banzi, Stephen Campbell, Bjorn Wettermark
Publikováno v:
BioMed Research International. 2023:1-3
Autor:
Brian Godman, Anna Bucsics, Patricia Vella Bonanno, Wija Oortwijn, Celia C. Rothe, Alessandra Ferrario, Simone Bosselli, Andrew Hill, Antony P. Martin, Steven Simoens, Amanj Kurdi, Mohamed Gad, Jolanta Gulbinovič, Angela Timoney, Tomasz Bochenek, Ahmed Salem, Iris Hoxha, Robert Sauermann, Amos Massele, Augusto Alfonso Guerra, Guenka Petrova, Zornitsa Mitkova, Gnosia Achniotou, Ott Laius, Catherine Sermet, Gisbert Selke, Vasileios Kourafalos, John Yfantopoulos, Einar Magnusson, Roberta Joppi, Margaret Oluka, Hye-Young Kwon, Arianit Jakupi, Francis Kalemeera, Joseph O. Fadare, Oyvind Melien, Maciej Pomorski, Magdalene Wladysiuk, Vanda Marković-Peković, Ileana Mardare, Dmitry Meshkov, Tanja Novakovic, Jurij Fürst, Dominik Tomek, Corrine Zara, Eduardo Diogene, Johanna C. Meyer, Rickard Malmström, Björn Wettermark, Zinhle Matsebula, Stephen Campbell, Alan Haycox
Publikováno v:
Frontiers in Public Health, Vol 6 (2018)
Introduction: There is continued unmet medical need for new medicines across countries especially for cancer, immunological diseases, and orphan diseases. However, there are growing challenges with funding new medicines at ever increasing prices alon
Externí odkaz:
https://doaj.org/article/44e09c6a8ab54400ba7f5f970ab42861
Autor:
Maria Karelou, Vasileios Kourafalos, Athanasia P. Tragomalou, Panagiotis Marakos, Nicole Pouli, Ourania E. Tsitsilonis, Evangelos Gikas, Ioannis K. Kostakis
Publikováno v:
Molecules, Vol 25, Iss 19, p 4584 (2020)
Several new amino-substituted aza-acridine derivatives bearing a basic side chain have been designed and synthesized. The antiproliferative activity of the target compounds has been evaluated against three cancer cell lines—namely HCT-116 (colorect
Externí odkaz:
https://doaj.org/article/81e355f07b9f490fb83d395ad09ffe8e
Autor:
Mikael Hoffmann, Stuart McTaggart, Vanda Marković-Peković, Irene Langner, Skule Ingeberg, Iva Selke Krulichová, Carol Holmes, Juraj Slabý, Brian Godman, Biljana Tubić, Svens Henkuzens, Corinne Zara, Jakub Rutkowski, Jurij Fürst, András Inotai, Stephen Campbell, Konstantin Tachkov, Sean MacBride-Stewart, Ileana Mardare, Mihajlo Jakovljevic, Kristina Garuolienė, Marta Turu Pedrola, Øyvind Melien, Gisbert Selke, Magdalene Wladysiuk, Björn Wettermark, Amanj Kurdi, Arianit Jakupi, Caridad Pontes, Vasileios Kourafalos, Manfred Hinteregger, Eleonora Allocati, Radka Nejezchlebova, Guenka Petrova, Francis Kalemeera, Rita Banzi, András Harsányi, Patricia Vella Bonanno, Ott Laius, Robert Sauermann, Alice Pisana, Jolanta Gulbinovič, Anna Nachtnebel, Iris Hoxha
Publikováno v:
BioMed research international, London : Hindawi Ltd., 2021, vol. 2021, art. no. 9996193, p. [1-16]
BioMed Research International
BioMed Research International, Vol 2021 (2021)
BioMed Research International
BioMed Research International, Vol 2021 (2021)
Background. Diabetes mellitus rates and associated costs continue to rise across Europe enhancing health authority focus on its management. The risk of complications is enhanced by poor glycaemic control, with long-acting insulin analogues developed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1f71eb049d04b088f4f63846e1ca06c
https://repository.vu.lt/VU:ELABAPDB116509835&prefLang=en_US
https://repository.vu.lt/VU:ELABAPDB116509835&prefLang=en_US
Autor:
Vasileios Kourafalos, Eleonora Allocati, Luka Voncina, Brian Godman, Arianit Jakupi, Robert Plisko, Evelien Moorkens, Kateřina Kohoutová, Nataša Grubiša, Gisbert Selke, Anita Viksna, Arnold G. Vulto, Jurij Fürst, Jaana E. Martikainen, Leona Popelková, Ileana Mardare, Patricia Vella Bonanno, Vincent Suttorp, Dorthe Bartels, Sarah Mörtenhuber, Ott Laius, Iris Hoxha, Gustaf Befrits, Isabelle Huys, Dmitry Meshkov, Gnosia Achniotou, Rannveig Einarsdóttir, Øyvind Melien, Juraj Slabý, Ieva Greičiūtė-Kuprijanov, Simon Keuerleber, Einar Magnusson, Corinne Zara, Admir Malaj, Robert Puckett, Silvia Stockinger, Vanda Marković-Peković, Maria Dimitrova, Vera Vlahović Palčevski, Konstantin Tachkov, Tanja Novakovic, Roisin Adams, Roberta Joppi
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
Frontiers in Pharmacology, 11:591134. Frontiers Media S.A.
Frontiers in Pharmacology
Volume 11
Frontiers in Pharmacology, 11:591134. Frontiers Media S.A.
Frontiers in Pharmacology
Volume 11
Background: From October 2018, adalimumab biosimilars could enter the European market. However, in some countries, such as Netherlands, high discounts reported for the originator product may have influenced biosimilar entry.Objectives: The aim of thi
Autor:
Nicole Pouli, Vasileios Kourafalos, Ourania E. Tsitsilonis, Maria Karelou, Athanasia Tragomalou, Panagiotis Marakos, Ioannis K. Kostakis, Evangelos Gikas
Publikováno v:
Molecules
Molecules, Vol 25, Iss 4584, p 4584 (2020)
Volume 25
Issue 19
Molecules, Vol 25, Iss 4584, p 4584 (2020)
Volume 25
Issue 19
Several new amino-substituted aza-acridine derivatives bearing a basic side chain have been designed and synthesized. The antiproliferative activity of the target compounds has been evaluated against three cancer cell lines&mdash
namely HCT-116
namely HCT-116
Autor:
Evelien, Moorkens, Brian, Godman, Isabelle, Huys, Iris, Hoxha, Admir, Malaj, Simon, Keuerleber, Silvia, Stockinger, Sarah, Mörtenhuber, Maria, Dimitrova, Konstantin, Tachkov, Luka, Vončina, Vera Vlahović, Palčevski, Gnosia, Achniotou, Juraj, Slabý, Leona, Popelková, Kateřina, Kohoutová, Dorthe, Bartels, Ott, Laius, Jaana E, Martikainen, Gisbert W, Selke, Vasileios, Kourafalos, Einar, Magnússon, Rannveig, Einarsdóttir, Roisín, Adams, Roberta, Joppi, Eleonora, Allocati, Arianit, Jakupi, Anita, Viksna, Ieva, Greičiūtė-Kuprijanov, Patricia, Vella Bonanno, Vincent, Suttorp, Øyvind, Melien, Robert, Plisko, Ileana, Mardare, Dmitry, Meshkov, Tanja, Novakovic, Jurij, Fürst, Corinne, Zara, Vanda, Marković-Peković, Nataša, Grubiša, Gustaf, Befrits, Robert, Puckett, Arnold G, Vulto
Publikováno v:
Frontiers in Pharmacology
Background: From October 2018, adalimumab biosimilars could enter the European market. However, in some countries, such as Netherlands, high discounts reported for the originator product may have influenced biosimilar entry. Objectives: The aim of th